Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply

Affiliations

Comment

Otavio Berwanger et al. N Engl J Med. 2021.

. 2021 Mar 11;384(10):975-976.

doi: 10.1056/NEJMc2035891.

No abstract available

Comment on

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Verma A, Dhingra N, Yanagawa B. Verma A, et al. N Engl J Med. 2021 Mar 11;384(10):973-974. doi: 10.1056/NEJMc2035891. N Engl J Med. 2021. PMID: 33704949 No abstract available.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Lotlikar A, Anwar S. Lotlikar A, et al. N Engl J Med. 2021 Mar 11;384(10):974. doi: 10.1056/NEJMc2035891. N Engl J Med. 2021. PMID: 33704950 No abstract available.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Alghamry A, Lee JC. Alghamry A, et al. N Engl J Med. 2021 Mar 11;384(10):974-975. doi: 10.1056/NEJMc2035891. N Engl J Med. 2021. PMID: 33704951 No abstract available.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Duraes AR, Bitar YSL. Duraes AR, et al. N Engl J Med. 2021 Mar 11;384(10):975. doi: 10.1056/NEJMc2035891. N Engl J Med. 2021. PMID: 33704952 No abstract available.